Titre:
  • Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.
Auteur:Najem, Ahmad; Krayem, Mohammad; Sabbah, Serena; Pesetti, Matilde; Journe, Fabrice; Awada, Ahmad; Désaubry, Laurent; Ghanem, Ghanem E
Informations sur la publication:Cells, 12, 14
Statut de publication:Publié, 2023-07-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:MAPKi
drug resistance
melanoma
mitochondria-targeted agents (MTA)
prohibitins
therapeutic strategy
MeSH keywords:Humans
Melanoma -- pathology
Skin Neoplasms -- drug therapy
Prohibitins
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins B-raf -- metabolism
Ligands
Protein Kinase Inhibitors -- pharmacology
Drug Resistance, Neoplasm
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2073-4409
info:doi/10.3390/cells12141855
info:pii/cells12141855
info:scp/85166005416
info:pmid/37508519
PMC10378173